These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 8395592
1. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH. J Neurosurg; 1993 Sep; 79(3):400-7. PubMed ID: 8395592 [Abstract] [Full Text] [Related]
2. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH. Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127 [Abstract] [Full Text] [Related]
3. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH. J Neurosurg; 1994 Aug 01; 81(2):256-60. PubMed ID: 8027810 [Abstract] [Full Text] [Related]
4. Toxicity studies and distribution dynamics of retroviral vectors following intrathecal administration of retroviral vector-producer cells. Oshiro EM, Viola JJ, Oldfield EH, Walbridge S, Bacher J, Frank JA, Blaese RM, Ram Z. Cancer Gene Ther; 1995 Jun 01; 2(2):87-95. PubMed ID: 7621261 [Abstract] [Full Text] [Related]
6. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. Ram Z, Walbridge S, Heiss JD, Culver KW, Blaese RM, Oldfield EH. J Neurosurg; 1994 Mar 15; 80(3):535-40. PubMed ID: 8113867 [Abstract] [Full Text] [Related]
7. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir. Namba H, Tagawa M, Miyagawa T, Iwadate Y, Sakiyama S. Cancer Gene Ther; 2000 Jun 15; 7(6):947-53. PubMed ID: 10880027 [Abstract] [Full Text] [Related]
8. Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration. Packer RJ, Raffel C, Villablanca JG, Tonn JC, Burdach SE, Burger K, LaFond D, McComb JG, Cogen PH, Vezina G, Kapcala LP. J Neurosurg; 2000 Feb 15; 92(2):249-54. PubMed ID: 10659011 [Abstract] [Full Text] [Related]
9. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm. Rainov NG, Kramm CM, Aboody-Guterman K, Chase M, Ueki K, Louis DN, Harsh GR, Chiocca A, Breakefield XO. Cancer Gene Ther; 1996 Feb 15; 3(2):99-106. PubMed ID: 8729908 [Abstract] [Full Text] [Related]
10. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S. Hum Gene Ther; 1995 Sep 15; 6(9):1231-55. PubMed ID: 8527482 [Abstract] [Full Text] [Related]
11. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K. J Gene Med; 2004 Mar 15; 6(3):288-99. PubMed ID: 15026990 [Abstract] [Full Text] [Related]
12. Survival and toxicity of xenogeneic murine retroviral vector producer cells in liver. Moorman DW, Butler DA, Stanley JD, Lamsam JL, Ackermann MR, Jacobson CD, Culver KW. J Surg Oncol; 1994 Nov 15; 57(3):152-6. PubMed ID: 7967603 [Abstract] [Full Text] [Related]
13. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF. Hum Gene Ther; 1993 Feb 15; 4(1):39-69. PubMed ID: 8384892 [Abstract] [Full Text] [Related]
14. Bystander-mediated regression of osteosarcoma via retroviral transfer of the herpes simplex virus thymidine kinase and human interleukin-2 genes. Walling HW, Swarthout JT, Culver KW. Cancer Gene Ther; 2000 Feb 15; 7(2):187-96. PubMed ID: 10770626 [Abstract] [Full Text] [Related]
15. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain. Colak A, Goodman JC, Chen SH, Woo SL, Grossman RG, Shine HD. Hum Gene Ther; 1995 Oct 15; 6(10):1317-22. PubMed ID: 8590736 [Abstract] [Full Text] [Related]
16. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene]. Quillien V, Heresbach Le Berre N, Dufour T, Denais A, Guegan Y, Ferry N, Bloin V. Bull Cancer; 1997 Nov 15; 84(11):1047-52. PubMed ID: 9536986 [Abstract] [Full Text] [Related]
17. An improved retroviral vector encoding the herpes simplex virus thymidine kinase gene increases antitumor efficacy in vivo. Lyons RM, Forry-Schaudies S, Otto E, Wey C, Patil-Koota V, Kaloss M, McGarrity GJ, Chiang YL. Cancer Gene Ther; 1995 Dec 15; 2(4):273-80. PubMed ID: 8548581 [Abstract] [Full Text] [Related]
18. Assessment of ganciclovir toxicity to experimental intracranial gliomas following recombinant adenoviral-mediated transfer of the herpes simplex virus thymidine kinase gene by magnetic resonance imaging and proton magnetic resonance spectroscopy. Ross BD, Kim B, Davidson BL. Clin Cancer Res; 1995 Jun 15; 1(6):651-7. PubMed ID: 9816028 [Abstract] [Full Text] [Related]
19. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC. Gene Ther; 2000 Sep 15; 7(17):1483-90. PubMed ID: 11001368 [Abstract] [Full Text] [Related]
20. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells. Berenstein M, Adris S, Ledda F, Wolfmann C, Medina J, Bravo A, Mordoh J, Chernajovsky Y, Podhajcer OL. Cancer Gene Ther; 1999 Sep 15; 6(4):358-66. PubMed ID: 10419054 [Abstract] [Full Text] [Related] Page: [Next] [New Search]